Avid Bioservices, Inc.
CDMO
$9.12
-$0.08-0.87%
| 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 33.82M | 25.40M | 37.73M | 39.80M | 38.02M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.82M | 25.40M | 37.73M | 39.80M | 38.02M |
| Cost of Revenue | 31.43M | 30.06M | 33.63M | 31.41M | 28.19M |
| Gross Profit | 2.38M | -4.67M | 4.10M | 8.39M | 9.83M |
| SG&A Expenses | 6.38M | 6.56M | 6.26M | 7.46M | 7.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.81M | 36.62M | 39.89M | 38.87M | 35.30M |
| Operating Income | -4.00M | -11.22M | -2.16M | 932.00K | 2.72M |
| Income Before Tax | -7.06M | -11.91M | -2.68M | 448.00K | 2.51M |
| Income Tax Expenses | -1.05M | -2.39M | -587.00K | 757.00K | 2.76M |
| Earnings from Continuing Operations | -6.01M | -9.52M | -2.09M | -309.00K | -247.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.01M | -9.52M | -2.09M | -309.00K | -247.00K |
| EBIT | -4.00M | -11.22M | -2.16M | 932.00K | 2.72M |
| EBITDA | -1.18M | -8.44M | 486.00K | 2.82M | 4.64M |
| EPS Basic | -0.09 | -0.15 | -0.03 | 0.00 | 0.00 |
| Normalized Basic EPS | -0.07 | -0.12 | -0.03 | 0.00 | 0.03 |
| EPS Diluted | -0.09 | -0.15 | -0.03 | 0.00 | 0.00 |
| Normalized Diluted EPS | -0.07 | -0.12 | -0.03 | 0.00 | 0.02 |
| Average Basic Shares Outstanding | 63.32M | 63.15M | 62.84M | 62.59M | 62.39M |
| Average Diluted Shares Outstanding | 63.32M | 63.15M | 62.84M | 62.59M | 69.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
